Opus Genetics, Inc. IRD
Set alert
3.94 USD +0.23 +6.35%
As of Nov 3, 2:37 PM ET
3.74 Day range 3.98
1.70 52-week range 7.07
- YTD
- +95.77%
- 1 year
- +83.88%
- Open
- 3.74
- Prev close
- 3.70
- Mkt cap
- 327.38M
- Vol
- 546.81K
- Avg vol
- 2.50M
- EPS
- -1.27
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.74
- High
- 3.98
- Forward P/E
- -1.20
- Beta
- 0.00
- Short ratio
- 4.69
- Inst. own
- 8.05%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.13
- 200-d avg
- 1.52
- 1y target
- 10.50
6M chart
Signals (24)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 3, 2026 | 5 hours ago |
| RSI: Oversold | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| RSI: Overbought | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| RSI: Oversold | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 5 months ago |
Newest 20 of 24.
Financial health
Altman Z-Score
-4.73 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.5×
FY 2019 5y median -0.6× FY 2025
P/S 88.1×
FY 2019 5y median 2.9× FY 2025
P/B 81.5×
FY 2019 5y median 0.9× FY 2025
P/FCF -35.5×
FY 2019 5y median -1.2× FY 2025
EV/EBITDA -25.1×
FY 2019 5y median -0.0× FY 2025
EV/Sales 84.9×
FY 2019 5y median -0.4× FY 2025
FCF Yield -2.8%
FY 2019 5y median -4.0% FY 2025
Profitability
Gross Margin 100.0%
FY 2019 5y median 100.0% FY 2025
Operating Margin -271.9%
FY 2019 5y median -271.9% FY 2025
Net Margin -349.3%
FY 2019 5y median -349.3% FY 2025
ROE -323.1%
FY 2019 5y median -255.1% FY 2025
ROIC -90.9%
FY 2019 5y median -90.9% FY 2025
ROA -98.7%
FY 2019 5y median -98.7% FY 2025
Growth (YoY)
Revenue 29.1%
FY 2019 FY 2025
Operating Income 37.8%
FY 2019 FY 2025
EPS (diluted) 62.8%
FY 2019 FY 2025
Free Cash Flow -37.8%
FY 2019 FY 2025
Financial Health
Current Ratio 6.4×
FY 2019 5y median 6.8× FY 2025
Quick Ratio 6.4×
FY 2019 5y median 6.8× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2019 5y median 0.5× FY 2025
Interest Coverage -26.3×
FY 2019 5y median -8.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
